{
    "nctId": "NCT00967824",
    "briefTitle": "Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer",
    "officialTitle": "Developing and Testing a Tamoxifen Prophylaxis Decision Aid",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1683,
    "primaryOutcomeMeasure": "Development and testing of a decision aid that describes the risks and benefits of taking tamoxifen citrate to prevent primary breast cancer",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Believed to be at increased risk of breast cancer (risk of \u2265 1.66% over 5 years) according to electronic-based medical data\n\nPATIENT CHARACTERISTICS:\n\n* Not specified\n\nPRIOR CONCURRENT THERAPY:\n\n* Not specified",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}